P29033 (CXB2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 152.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Gap junction beta-2 protein Alternative name(s): Connexin-26 Short name=Cx26 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 226 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. |
| Subunit structure | A connexon is composed of a hexamer of connexins. Interacts with CNST By similarity. Ref.11 |
| Subcellular location | Cell membrane; Multi-pass membrane protein. Cell junction › gap junction. |
| Involvement in disease | Deafness, autosomal recessive, 1A (DFNB1A) [MIM:220290]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. Deafness, autosomal dominant, 3A (DFNA3A) [MIM:601544]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. Vohwinkel syndrome (VS) [MIM:124500]: VS is an autosomal dominant disease characterized by hyperkeratosis, constriction on fingers and toes and congenital deafness. Keratoderma, palmoplantar, with deafness (PPKDFN) [MIM:148350]: An autosomal dominant disorder characterized by the association of palmoplantar hyperkeratosis with progressive, bilateral, high-frequency, sensorineural deafness. Keratitis-ichthyosis-deafness syndrome (KID syndrome) [MIM:148210]: An autosomal dominant form of ectodermal dysplasia. Ectodermal dysplasia defines a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures. Keratitis-ichthyosis-deafness syndrome is characterized by the association of hyperkeratotic skin lesions with vascularizing keratitis and profound sensorineural hearing loss. Clinical features include deafness, ichthyosis, photobia, absent or decreased eyebrows, sparse or absent scalp hair, decreased sweating and dysplastic finger and toenails. Bart-Pumphrey syndrome (BPS) [MIM:149200]: An autosomal dominant disorder characterized by sensorineural hearing loss, palmoplantar keratoderma, knuckle pads, and leukonychia, It shows considerable phenotypic variability. Ichthyosis hystrix-like with deafness syndrome (HID syndrome) [MIM:602540]: An autosomal dominant keratinizing disorder characterized by sensorineural deafness and spiky hyperkeratosis affecting the entire skin. HID syndrome is considered to differ from the similar KID syndrome in the extent and time of occurrence of skin symptoms and the severity of the associated keratitis. |
| Sequence similarities | Belongs to the connexin family. Beta-type (group I) subfamily. |
| Caution | The Thr-34 allele was originally thought to be a cause of autosomal dominant and recessive deafness (DFNA3 and DFNB1) (Ref.12). However, Thr-34 effect on hearing is controversial. Some studies supports its pathogenic role (Ref.45 and Ref.44). Others provide evidence of the non-pathogenic nature of this variant (Ref.13 and Ref.39). |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 226 | 226 | Gap junction beta-2 protein | PRO_0000057855 | |||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||
| Topological domain | 1 – 20 | 20 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||
| Transmembrane | 21 – 40 | 20 | Helical; Potential | ||||||||||||||||||||||||||||||||
| Topological domain | 41 – 75 | 35 | Extracellular Potential | ||||||||||||||||||||||||||||||||
| Transmembrane | 76 – 98 | 23 | Helical; Potential | ||||||||||||||||||||||||||||||||
| Topological domain | 99 – 131 | 33 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||
| Transmembrane | 132 – 154 | 23 | Helical; Potential | ||||||||||||||||||||||||||||||||
| Topological domain | 155 – 192 | 38 | Extracellular Potential | ||||||||||||||||||||||||||||||||
| Transmembrane | 193 – 215 | 23 | Helical; Potential | ||||||||||||||||||||||||||||||||
| Topological domain | 216 – 226 | 11 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Disulfide bond | 53 ↔ 180 | Ref.11 | |||||||||||||||||||||||||||||||||
| Disulfide bond | 60 ↔ 174 | Ref.11 | |||||||||||||||||||||||||||||||||
| Disulfide bond | 64 ↔ 169 | Ref.11 | |||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Natural variant | 12 | 1 | G → R in KID syndrome. Ref.28 | VAR_015453 | |||||||||||||||||||||||||||||||
| Natural variant | 17 | 1 | S → F in KID syndrome. Ref.28 Corresponds to variant rs28929485 [ dbSNP | Ensembl ]. | VAR_015454 | |||||||||||||||||||||||||||||||
| Natural variant | 27 | 1 | V → I. Ref.4 Ref.9 Ref.16 Ref.22 Ref.36 Ref.38 Ref.49 Corresponds to variant rs2274084 [ dbSNP | Ensembl ]. | VAR_002137 | |||||||||||||||||||||||||||||||
| Natural variant | 32 | 1 | R → H in DFNB1A. Ref.4 | VAR_023605 | |||||||||||||||||||||||||||||||
| Natural variant | 32 | 1 | R → L. Ref.6 | VAR_016839 | |||||||||||||||||||||||||||||||
| Natural variant | 34 | 1 | M → T Frequently found in deafness patients; it is correctly synthesized and targeted to the plasma membrane; it inefficiently forms intercellular channels that display an abnormal electrical behavior; uncertain pathological significance. Ref.12 Ref.13 Ref.18 Ref.39 Ref.44 Ref.45 Corresponds to variant rs35887622 [ dbSNP | Ensembl ]. | VAR_002138 | |||||||||||||||||||||||||||||||
| Natural variant | 37 | 1 | V → I in DFNB1A; was reported first as a polymorphism. Ref.3 Ref.16 Ref.22 Ref.24 Ref.31 Ref.35 Ref.36 Ref.45 | VAR_002139 | |||||||||||||||||||||||||||||||
| Natural variant | 44 | 1 | W → C in DFNA3A. Ref.19 | VAR_008709 | |||||||||||||||||||||||||||||||
| Natural variant | 44 | 1 | W → S in DFNA3A; does not affect protein trafficking; affects the ability to form functional channels; dominant negative effect. Ref.37 | VAR_032749 | |||||||||||||||||||||||||||||||
| Natural variant | 45 | 1 | G → E in deafness. Ref.36 | VAR_015455 | |||||||||||||||||||||||||||||||
| Natural variant | 46 – 48 | 3 | DEQ → E May contribute to deafness. Ref.50 | VAR_023606 | |||||||||||||||||||||||||||||||
| Natural variant | 46 | 1 | D → E in DFNA3A; the mutant is targeted to the plasma membrane but failes to transfer ionic calcium or propidium iodide intercellularly suggesting disruption of both ionic and biochemical coupling; heterozygous gap junctions also show dysfunctional intercellular couplings and hemichannel opening confirming the dominant-negative nature of the mutation. Ref.50 | VAR_060798 | |||||||||||||||||||||||||||||||
| Natural variant | 50 | 1 | D → N in KID syndrome and HID syndrome. Ref.28 Ref.30 Ref.33 Ref.34 Corresponds to variant rs28931594 [ dbSNP | Ensembl ]. | VAR_015456 | |||||||||||||||||||||||||||||||
| Natural variant | 50 | 1 | D → Y in KID syndrome. Ref.34 | VAR_015935 | |||||||||||||||||||||||||||||||
| Natural variant | 54 | 1 | N → K in BPS. Ref.40 | VAR_032750 | |||||||||||||||||||||||||||||||
| Natural variant | 59 | 1 | G → A in PPKDFN; impairs trafficking; localizes intracellularly closed to the nucleus; affects the ability to form functional channels; phenotype can be rescued by coexpression with wild-type protein. Ref.25 Ref.37 | VAR_009965 | |||||||||||||||||||||||||||||||
| Natural variant | 59 | 1 | G → S in BPS. Ref.41 | VAR_032751 | |||||||||||||||||||||||||||||||
| Natural variant | 66 | 1 | D → H in VS and PPKDFN; impairs trafficking; localizes intracellularly closed to the nucleus; affects the ability to form functional channels; phenotype can be rescued by coexpression with wild-type protein. Ref.21 Ref.23 Ref.37 | VAR_008710 | |||||||||||||||||||||||||||||||
| Natural variant | 71 | 1 | I → T in deafness. Ref.36 | VAR_015457 | |||||||||||||||||||||||||||||||
| Natural variant | 73 | 1 | H → R in PPKDFN; the mutant has a dominant-negative effect on connexin trafficking. Ref.47 | VAR_060799 | |||||||||||||||||||||||||||||||
| Natural variant | 75 | 1 | R → Q in PPKDFN; the mutant protein completely prevents the formation of functional channels. Ref.32 Ref.42 | VAR_015936 | |||||||||||||||||||||||||||||||
| Natural variant | 75 | 1 | R → W in PPKDFN and DFNA3A; does not affect protein trafficking; affects the ability to form functional channels; dominant negative effect. Ref.17 Ref.37 | VAR_002140 | |||||||||||||||||||||||||||||||
| Natural variant | 77 | 1 | W → R in DFNB1A. Ref.14 | VAR_002141 | |||||||||||||||||||||||||||||||
| Natural variant | 79 | 1 | L → P in DFNB1A. Ref.2 | VAR_023607 | |||||||||||||||||||||||||||||||
| Natural variant | 80 | 1 | Q → K in DFNB1A. Ref.4 | VAR_023608 | |||||||||||||||||||||||||||||||
| Natural variant | 83 | 1 | F → L. Ref.18 | VAR_002142 | |||||||||||||||||||||||||||||||
| Natural variant | 84 | 1 | V → L in DFNB1A; sorted to the plasma membrane normally and forms gap junctions that were morphologically and electrically indistinguishable from those of control; the mutation reduces the permeability of GJB2 gap junction channels to inositol 1,4,5-trisphosphate (Ins(1,4,5)P3), resulting in blockade of the Ins(1,4,5)P3-induced inward calcium current in neighboring cells. Ref.16 Ref.43 | VAR_002143 | |||||||||||||||||||||||||||||||
| Natural variant | 84 | 1 | V → M in DFNB1A; the mutant disrupts cellular communication. Ref.46 | VAR_060800 | |||||||||||||||||||||||||||||||
| Natural variant | 86 | 1 | T → R in DFNB1A; does not form gap junctions since the mutated protein is confined in the cytoplasm and not transported to the cell membrane; when the mutation is coexpressed with the wild-type protein ionic and biochemical coupling is normal consistent with the recessive nature of the mutation. Ref.36 Ref.50 | VAR_015458 | |||||||||||||||||||||||||||||||
| Natural variant | 90 | 1 | L → P in DFNB1A. Ref.24 Ref.27 | VAR_015937 | |||||||||||||||||||||||||||||||
| Natural variant | 93 | 1 | M → I in DFNB1A. Ref.4 | VAR_023609 | |||||||||||||||||||||||||||||||
| Natural variant | 95 | 1 | V → M in DFNB1A. Ref.16 | VAR_002144 | |||||||||||||||||||||||||||||||
| Natural variant | 111 | 1 | I → T. Ref.38 | VAR_015938 | |||||||||||||||||||||||||||||||
| Natural variant | 113 | 1 | S → R in DFNB1A. Ref.16 | VAR_002145 | |||||||||||||||||||||||||||||||
| Natural variant | 114 | 1 | E → G. Ref.4 Ref.9 Ref.22 Ref.36 Ref.38 Corresponds to variant rs2274083 [ dbSNP | Ensembl ]. | VAR_009966 | |||||||||||||||||||||||||||||||
| Natural variant | 118 | 1 | Missing in DFNB1A. | VAR_060801 | |||||||||||||||||||||||||||||||
| Natural variant | 120 | 1 | Missing in DFNB1A. Ref.4 | VAR_023610 | |||||||||||||||||||||||||||||||
| Natural variant | 123 | 1 | T → N. Ref.36 | VAR_015459 | |||||||||||||||||||||||||||||||
| Natural variant | 127 | 1 | R → H Very common polymorphism in India. Ref.3 Ref.4 Ref.38 | VAR_015939 | |||||||||||||||||||||||||||||||
| Natural variant | 129 | 1 | E → K in DFNB1A. Ref.4 | VAR_023611 | |||||||||||||||||||||||||||||||
| Natural variant | 143 | 1 | R → Q in DFNA3A. Ref.27 | VAR_015940 | |||||||||||||||||||||||||||||||
| Natural variant | 143 | 1 | R → W in DFNB1A. Ref.2 Ref.4 Ref.20 Ref.36 | VAR_015460 | |||||||||||||||||||||||||||||||
| Natural variant | 153 | 1 | V → I May contribute to deafness. Ref.3 Ref.4 Ref.38 | VAR_009967 | |||||||||||||||||||||||||||||||
| Natural variant | 159 | 1 | D → V in DFNB1A. Ref.29 Corresponds to variant rs28931592 [ dbSNP | Ensembl ]. | VAR_015941 | |||||||||||||||||||||||||||||||
| Natural variant | 160 | 1 | G → S. Ref.3 Ref.18 Corresponds to variant rs34988750 [ dbSNP | Ensembl ]. | VAR_002146 | |||||||||||||||||||||||||||||||
| Natural variant | 165 | 1 | R → W. Ref.38 | VAR_015942 | |||||||||||||||||||||||||||||||
| Natural variant | 167 | 1 | V → M May contribute to deafness. Ref.3 | VAR_023612 | |||||||||||||||||||||||||||||||
| Natural variant | 168 | 1 | K → R in a patient with congenital erythrokeratodermia; unknown pathological significance. Ref.48 | VAR_057959 | |||||||||||||||||||||||||||||||
| Natural variant | 169 | 1 | C → Y. | VAR_009968 | |||||||||||||||||||||||||||||||
| Natural variant | 178 | 1 | V → A in DFNB1A. Ref.2 | VAR_023613 | |||||||||||||||||||||||||||||||
| Natural variant | 179 | 1 | D → N in DFNA3A. Ref.35 Corresponds to variant rs28931595 [ dbSNP | Ensembl ]. | VAR_032752 | |||||||||||||||||||||||||||||||
| Natural variant | 184 | 1 | R → P in DFNB1A. Ref.4 Ref.15 | VAR_015943 | |||||||||||||||||||||||||||||||
| Natural variant | 184 | 1 | R → Q in DFNA3A. Ref.2 | VAR_023614 | |||||||||||||||||||||||||||||||
| Natural variant | 184 | 1 | R → W in DFNB1A. Ref.24 | VAR_009969 | |||||||||||||||||||||||||||||||
| Natural variant | 191 | 1 | F → L. Ref.36 | VAR_015461 | |||||||||||||||||||||||||||||||
| Natural variant | 197 | 1 | A → S in DFNA3A. Ref.2 | VAR_023615 | |||||||||||||||||||||||||||||||
| Natural variant | 202 | 1 | C → F in DFNA3A. Ref.26 | VAR_015944 | |||||||||||||||||||||||||||||||
| Natural variant | 203 | 1 | I → K in DFNB1A. Ref.2 | VAR_023616 | |||||||||||||||||||||||||||||||
| Natural variant | 203 | 1 | I → T. Ref.22 Ref.36 | VAR_009970 | |||||||||||||||||||||||||||||||
| Natural variant | 214 | 1 | L → P in DFNB1A. Ref.2 | VAR_023617 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Sequence conflict | 86 | 1 | T → S in AAD21314. Ref.1 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 112 | 1 | K → N in AAY25170. Ref.4 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Helix | 5 – 11 | 7 | |||||||||||||||||||||||||||||||||
| Helix | 22 – 43 | 22 | |||||||||||||||||||||||||||||||||
| Helix | 46 – 49 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 52 – 54 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 60 – 66 | 7 | |||||||||||||||||||||||||||||||||
| Helix | 73 – 83 | 11 | |||||||||||||||||||||||||||||||||
| Helix | 85 – 105 | 21 | |||||||||||||||||||||||||||||||||
| Turn | 106 – 108 | 3 | |||||||||||||||||||||||||||||||||
| Turn | 126 – 130 | 5 | |||||||||||||||||||||||||||||||||
| Helix | 131 – 156 | 26 | |||||||||||||||||||||||||||||||||
| Turn | 157 – 159 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 160 – 162 | 3 | |||||||||||||||||||||||||||||||||
| Beta strand | 165 – 169 | 5 | |||||||||||||||||||||||||||||||||
| Beta strand | 174 – 181 | 8 | |||||||||||||||||||||||||||||||||
| Helix | 185 – 215 | 31 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines." Lee S.W., Tomasetto C., Paul D., Keyomarsi K., Sager R. J. Cell Biol. 118:1213-1221(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana." Hamelmann C., Amedofu G.K., Albrecht K., Muntau B., Gelhaus A., Brobby G.W., Horstmann R.D. Hum. Mutat. 18:84-85(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS DFNB1A PRO-79; TRP-143; ALA-178; LYS-203 AND PRO-214, VARIANTS DFNA3A GLN-184 AND SER-197. Tissue: Blood. |
| [3] | "Low frequency of deafness-associated GJB2 variants in Kenya and Sudan and novel GJB2 variants." Gasmelseed N.M.A., Schmidt M., Magzoub M.M.A., Macharia M., Elmustafa O.M., Ototo B., Winkler E., Ruge G., Horstmann R.D., Meyer C.G. Hum. Mutat. 23:206-207(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT DFNB1A ILE-37, VARIANTS 46-ASP--GLN-48 DELINS GLU; HIS-127; ILE-153; SER-160 AND MET-167. |
| [4] | "GJB2 mutations: passage through Iran." Najmabadi H., Nishimura C., Kahrizi K., Riazalhosseini Y., Malekpour M., Daneshi A., Farhadi M., Mohseni M., Mahdieh N., Ebrahimi A., Bazazzadegan N., Naghavi A., Avenarius M., Arzhangi S., Smith R.J.H. Am. J. Med. Genet. A 133:132-137(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS DFNB1A HIS-32; LYS-80; ILE-93; GLU-120 DEL; LYS-129; TRP-143 AND PRO-184, VARIANTS ILE-27; GLY-114; HIS-127 AND ILE-153. |
| [5] | "A polymorphism in the genomic sequence of the coding region of connexin 26 in the South Indian population." Joseph A.Y., Rasool T.J. Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [6] | "A novel mutation in the connexin 26 gene in the South Indian population." Joseph A.Y., Rasool T.J. Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT LEU-32. |
| [7] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [8] | "The DNA sequence and analysis of human chromosome 13." Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T. Ross M.T.Nature 428:522-528(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS ILE-27 AND GLY-114. Tissue: Colon. |
| [10] | "A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment." del Castillo F.J., Rodriguez-Ballesteros M., Alvarez A., Hutchin T., Leonardi E., de Oliveira C.A., Azaiez H., Brownstein Z., Avenarius M.R., Marlin S., Pandya A., Shahin H., Siemering K.R., Weil D., Wuyts W., Aguirre L.A., Martin Y., Moreno-Pelayo M.A. del Castillo I.J. Med. Genet. 42:588-594(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN DFNB1A. |
| [11] | "Structure of the connexin 26 gap junction channel at 3.5 A resolution." Maeda S., Nakagawa S., Suga M., Yamashita E., Oshima A., Fujiyoshi Y., Tsukihara T. Nature 458:597-602(2009) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS), SUBUNIT, DISULFIDE BONDS. |
| [12] | "Connexin 26 mutations in hereditary non-syndromic sensorineural deafness." Kelsell D.P., Dunlop J., Stevens H.P., Lench N.J., Liang J.N., Parry G., Mueller R.F., Leigh I.M. Nature 387:80-83(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT THR-34. |
| [13] | "Connexin mutations and hearing loss." Scott D.A., Kraft M.L., Tone M.M., Sheffield V.C., Smith R.J.H. Nature 391:32-32(1998) [PubMed] [Europe PMC] [Abstract] Cited for: SHOWS THAT VARIANT THR-34 IS NOT A CAUSE OF DEAFNESS. |
| [14] | "Two different connexin 26 mutations in an inbred kindred segregating non-syndromic recessive deafness: implications for genetic studies in isolated populations." Carrasquillo M.M., Zlotogora J., Barges S., Chakravarti A. Hum. Mol. Genet. 6:2163-2172(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNB1A ARG-77. |
| [15] | "Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene." Denoyelle F., Weil D., Maw M.A., Wilcox S.A., Lench N.J., Allen-Powell D.R., Osborn A.H., Dahl H.-H.M., Middleton A., Houseman M.J., Dode C., Marlin S., Boulila-ElGaied A., Grati M., Ayadi H., BenArab S., Bitoun P., Lina-Granade G. Petit C.Hum. Mol. Genet. 6:2173-2177(1997) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS DFNB1A GLU-118 DEL AND PRO-184. |
| [16] | "Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss." Kelley P.M., Harris D.J., Comer B.C., Askew J.W., Fowler T., Smith S.D., Kimberling W.J. Am. J. Hum. Genet. 62:792-799(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS DFNB1A LEU-84; MET-95 AND ARG-113, VARIANTS ILE-27 AND ILE-37. |
| [17] | "Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma." Richard G., White T.W., Smith L.E., Bailey R.A., Compton J.G., Paul D.L., Bale S.J. Hum. Genet. 103:393-399(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PPKDFN TRP-75. |
| [18] | "Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss." Scott D.A., Kraft M.L., Carmi R., Ramesh A., Elbedour K., Yairi Y., Srikumari Srisailapathy C.R., Rosengren S.S., Markham A.F., Mueller R.F., Lench N.J., van Camp G., Smith R.J.H., Sheffield V.C. Hum. Mutat. 11:387-394(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS THR-34; LEU-83 AND SER-160. |
| [19] | "Connexin 26 gene linked to a dominant deafness." Denoyelle F., Lina-Granade G., Plauchu H., Bruzzone R., Chaib H., Levi-Acobas F., Weil D., Petit C. Nature 393:319-320(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNA3A CYS-44. |
| [20] | "Connexin 26 R143W mutation associated with recessive nonsyndromic sensorineural deafness in Africa." Brobby G.W., Muller-Myhsok B., Horstmann R.D. N. Engl. J. Med. 338:548-550(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNB1A TRP-143. |
| [21] | "A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families." Maestrini E., Korge B.P., Ocana-Sierra J., Calzolari E., Cambiaghi S., Scudder P.M., Hovnanian A., Monaco A.P., Munro C.S. Hum. Mol. Genet. 8:1237-1243(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT VS HIS-66. |
| [22] | "Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafness in the Japanese population." Kudo T., Ikeda K., Kure S., Matsubara Y., Oshima T., Watanabe K., Kawase T., Narisawa K., Takasaka T. Am. J. Med. Genet. 90:141-145(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ILE-27; ILE-37; GLY-114 AND THR-203. |
| [23] | "Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family." Kelsell D.P., Wilgoss A.L., Richard G., Stevens H.P., Munro C.S., Leigh I.M. Eur. J. Hum. Genet. 8:141-144(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PPKDFN HIS-66. |
| [24] | "High frequency hearing loss correlated with mutations in the GJB2 gene." Wilcox S.A., Saunders K., Osborn A.H., Arnold A., Wunderlich J., Kelly T., Collins V., Wilcox L.J., McKinlay Gardner R.J., Kamarinos M., Cone-Wesson B., Williamson R., Dahl H.-H.M. Hum. Genet. 106:399-405(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS DFNB1A ILE-37; PRO-90 AND TRP-184. |
| [25] | "A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350)." Heathcote K., Syrris P., Carter N.D., Patton M.A. J. Med. Genet. 37:50-51(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PPKDFN ALA-59. |
| [26] | "A novel C202F mutation in the connexin26 gene (GJB2) associated with autosomal dominant isolated hearing loss." Morle L., Bozon M., Alloisio N., Latour P., Vandenberghe A., Plauchu H., Collet L., Edery P., Godet J., Lina-Granade G. J. Med. Genet. 37:368-370(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNA3A PHE-202. |
| [27] | "Sensorineural hearing loss and the incidence of Cx26 mutations in Austria." Loffler J., Nekahm D., Hirst-Stadlmann A., Gunther B., Menzel H.J., Utermann G., Janecke A.R. Eur. J. Hum. Genet. 9:226-230(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNB1A PRO-90, VARIANT DFNA3A GLN-143. |
| [28] | "Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome." Richard G., Rouan F., Willoughby C.E., Brown N., Chung P., Ryynanen M., Jabs E.W., Bale S.J., DiGiovanna J.J., Uitto J., Russell L. Am. J. Hum. Genet. 70:1341-1348(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS KID SYNDROME ARG-12; PHE-17 AND ASN-50. |
| [29] | "Exploring the clinical and epidemiological complexity of GJB2-linked deafness." Gualandi F., Ravani A., Berto A., Sensi A., Trabanelli C., Falciano F., Trevisi P., Mazzoli M., Tibiletti M.G., Cristofari E., Burdo S., Ferlini A., Martini A., Calzolari E. Am. J. Med. Genet. 112:38-45(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNB1A VAL-159. |
| [30] | "HID and KID syndromes are associated with the same connexin 26 mutation." van Geel M., van Steensel M.A.M., Kuester W., Hennies H.C., Happle R., Steijlen P.M., Koenig A. Br. J. Dermatol. 146:938-942(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT HID SYNDROME ASN-50. |
| [31] | "Homozygosity for the V37I Connexin 26 mutation in three unrelated children with sensorineural hearing loss." Bason L., Dudley T., Lewis K., Shah U., Potsic W., Ferraris A., Fortina P., Rappaport E., Krantz I.D. Clin. Genet. 61:459-464(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNB1A ILE-37. |
| [32] | "The novel R75Q mutation in the GJB2 gene causes autosomal dominant hearing loss and palmoplantar keratoderma in a Turkish family." Uyguner O., Tukel T., Baykal C., Eris H., Emiroglu M., Hafiz G., Ghanbari A., Baserer N., Yuksel-Apak M., Wollnik B. Clin. Genet. 62:306-309(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PPKDFN GLN-75. |
| [33] | "De novo mutation in the gene encoding connexin-26 (GJB2) in a sporadic case of keratitis-ichthyosis-deafness (KID) syndrome." Alvarez A., Del Castillo I., Pera A., Villamar M., Moreno-Pelayo M.A., Moreno F., Moreno R., Tapia M.C. Am. J. Med. Genet. A 117:89-91(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT KID SYNDROME ASN-50. |
| [34] | "Novel mutations in GJB2 encoding connexin-26 in Japanese patients with keratitis-ichthyosis-deafness syndrome." Yotsumoto S., Hashiguchi T., Chen X., Ohtake N., Tomitaka A., Akamatsu H., Matsunaga K., Shiraishi S., Miura H., Adachi J., Kanzaki T. Br. J. Dermatol. 148:649-653(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS KID SYNDROME ASN-50 AND TYR-50. |
| [35] | "A novel dominant missense mutation -- D179N -- in the GJB2 gene (connexin 26) associated with non-syndromic hearing loss." Primignani P., Castorina P., Sironi F., Curcio C., Ambrosetti U., Coviello D.A. Clin. Genet. 63:516-521(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNA3A ASN-179, VARIANT DFNB1A ILE-37. |
| [36] | "GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation." Ohtsuka A., Yuge I., Kimura S., Namba A., Abe S., Van Laer L., Van Camp G., Usami S. Hum. Genet. 112:329-333(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS DEAFNESS GLU-45; THR-71; ARG-86 AND TRP-143, VARIANTS ILE-27; ILE-37; GLY-114; ASN-123; LEU-191 AND THR-203. |
| [37] | "Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30." Marziano N.K., Casalotti S.O., Portelli A.E., Becker D.L., Forge A. Hum. Mol. Genet. 12:805-812(2003) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANTS DFNA3A SER-44 AND TRP-75, CHARACTERIZATION OF VARIANT PPKDFN ALA-59, CHARACTERIZATION OF VARIANT VS HIS-66. |
| [38] | "Contribution of connexin26 (GJB2) mutations and founder effect to non-syndromic hearing loss in India." Ramshankar M., Girirajan S., Dagan O., Ravi Shankar H.M., Jalvi R., Rangasayee R., Avraham K.B., Anand A. J. Med. Genet. 40:E68-E68(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ILE-27; THR-111; GLY-114; HIS-127; ILE-153 AND TRP-165. |
| [39] | "Clinical evidence of the nonpathogenic nature of the M34T variant in the connexin 26 gene." Feldmann D., Denoyelle F., Loundon N., Weil D., Garabedian E.N., Couderc R., Joannard A., Schmerber S., Delobel B., Leman J., Journel H., Catros H., Ferrec C., Drouin-Garraud V., Obstoy M.F., Moati L., Petit C., Marlin S. Eur. J. Hum. Genet. 12:279-284(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NON-PATHOGENIC ROLE OF VARIANT THR-34. |
| [40] | "Expanding the phenotypic spectrum of Cx26 disorders: Bart-Pumphrey syndrome is caused by a novel missense mutation in GJB2." Richard G., Brown N., Ishida-Yamamoto A., Krol A. J. Invest. Dermatol. 123:856-863(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT BPS LYS-54. |
| [41] | "G59S mutation in the GJB2 (connexin 26) gene in a patient with Bart-Pumphrey syndrome." Alexandrino F., Sartorato E.L., Marques-de-Faria A.P., Steiner C.E. Am. J. Med. Genet. A 136:282-284(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT BPS SER-59. |
| [42] | "Functional analysis of R75Q mutation in the gene coding for Connexin 26 identified in a family with nonsyndromic hearing loss." Piazza V., Beltramello M., Menniti M., Colao E., Malatesta P., Argento R., Chiarella G., Gallo L.V., Catalano M., Perrotti N., Mammano F., Cassandro E. Clin. Genet. 68:161-166(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PPKDFN GLN-75, CHARACTERIZATION OF VARIANT PPKDFN GLN-75. |
| [43] | "Impaired permeability to Ins(1,4,5)P3 in a mutant connexin underlies recessive hereditary deafness." Beltramello M., Piazza V., Bukauskas F.F., Pozzan T., Mammano F. Nat. Cell Biol. 7:63-69(2005) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANT DFNB1A LEU-84. |
| [44] | "Pathogenetic role of the deafness-related M34T mutation of Cx26." Bicego M., Beltramello M., Melchionda S., Carella M., Piazza V., Zelante L., Bukauskas F.F., Arslan E., Cama E., Pantano S., Bruzzone R., D'Andrea P., Mammano F. Hum. Mol. Genet. 15:2569-2587(2006) [PubMed] [Europe PMC] [Abstract] Cited for: CHARACTERIZATION OF VARIANT THR-34, PATHOGENIC ROLE OF VARIANT THR-34. |
| [45] | "M34T and V37I mutations in GJB2 associated hearing impairment: evidence for pathogenicity and reduced penetrance." Pollak A., Skorka A., Mueller-Malesinska M., Kostrzewa G., Kisiel B., Waligora J., Krajewski P., Oldak M., Korniszewski L., Skarzynski H., Ploski R. Am. J. Med. Genet. A 143:2534-2543(2007) [PubMed] [Europe PMC] [Abstract] Cited for: POSSIBLE PATHOGENICITY OF VARIANTS THR-34 AND ILE-37. |
| [46] | "A novel hearing-loss-related mutation occurring in the GJB2 basal promoter." Matos T.D., Caria H., Simoes-Teixeira H., Aasen T., Nickel R., Jagger D.J., O'Neill A., Kelsell D.P., Fialho G. J. Med. Genet. 44:721-725(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNB1A MET-84, CHARACTERIZATION OF VARIANT DFNB1A MET-84. |
| [47] | "A novel missense mutation in GJB2 disturbs gap junction protein transport and causes focal palmoplantar keratoderma with deafness." de Zwart-Storm E.A., Hamm H., Stoevesandt J., Steijlen P.M., Martin P.E., van Geel M., van Steensel M.A.M. J. Med. Genet. 45:161-166(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PPKDFN ARG-73, CHARACTERIZATION OF VARIANT PPKDFN ARG-73. |
| [48] | "Connexin mutations in Brazilian patients with skin disorders with or without hearing loss." Alexandrino F., de Oliveira C.A., Magalhaes R.F., Florence M.E., de Souza E.M., Sartorato E.L. Am. J. Med. Genet. A 149:681-684(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ARG-168. |
| [49] | "Novel mutation p.Gly59Arg in GJB6 encoding connexin 30 underlies palmoplantar keratoderma with pseudoainhum, knuckle pads and hearing loss." Nemoto-Hasebe I., Akiyama M., Kudo S., Ishiko A., Tanaka A., Arita K., Shimizu H. Br. J. Dermatol. 161:452-455(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ILE-27. |
| [50] | "Different functional consequences of two missense mutations in the GJB2 gene associated with non-syndromic hearing loss." Choi S.-Y., Park H.-J., Lee K.Y., Dinh E.H., Chang Q., Ahmad S., Lee S.H., Bok J., Lin X., Kim U.-K. Hum. Mutat. 30:E716-E727(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DFNA3A GLU-46, VARIANT DFNB1A ARG-86, CHARACTERIZATION OF VARIANT DFNA3A GLU-46, CHARACTERIZATION OF VARIANT DFNB1A ARG-86. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M86849 mRNA. Translation: AAD21314.1. AF281280 Genomic DNA. Translation: AAF91440.1. AF479776 Genomic DNA. Translation: AAL87696.1. AY255853 Genomic DNA. Translation: AAP34178.1. AY275646 Genomic DNA. Translation: AAQ94940.1. AY275647 Genomic DNA. Translation: AAQ94941.1. AY275648 Genomic DNA. Translation: AAQ94942.1. AY275649 Genomic DNA. Translation: AAQ94943.1. AY275650 Genomic DNA. Translation: AAQ94944.1. AY275651 Genomic DNA. Translation: AAQ94945.1. AY275652 Genomic DNA. Translation: AAQ94946.1. AY275653 Genomic DNA. Translation: AAQ94947.1. AY275654 Genomic DNA. Translation: AAQ94948.1. AY280971 Genomic DNA. Translation: AAQ17213.1. AY953438 Genomic DNA. Translation: AAY25169.1. AY953441 Genomic DNA. Translation: AAY25170.1. BT006732 mRNA. Translation: AAP35378.1. AL138688 Genomic DNA. Translation: CAC16959.1. BC017048 mRNA. Translation: AAH17048.1. BC071703 mRNA. Translation: AAH71703.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00019868. | ||||||||||||||||||||||||||||||
| PIR | A43424. | ||||||||||||||||||||||||||||||
| RefSeq | NP_003995.2. NM_004004.5. | ||||||||||||||||||||||||||||||
| UniGene | Hs.524894. Hs.714494. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | P29033. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| DIP | DIP-59742N. | ||||||||||||||||||||||||||||||
| IntAct | P29033. 1 interaction. | ||||||||||||||||||||||||||||||
Protein family/group databases | |||||||||||||||||||||||||||||||
| TCDB | 1.A.24.1.3. gap junction-forming connexin family. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P29033. | ||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||
| DMDM | 77416855. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PaxDb | P29033. | ||||||||||||||||||||||||||||||
| PRIDE | P29033. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| DNASU | 2706. | ||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000382844; ENSP00000372295; ENSG00000165474. ENST00000382848; ENSP00000372299; ENSG00000165474. | ||||||||||||||||||||||||||||||
| GeneID | 2706. | ||||||||||||||||||||||||||||||
| KEGG | hsa:2706. | ||||||||||||||||||||||||||||||
| UCSC | uc001umy.3. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 2706. | ||||||||||||||||||||||||||||||
| GeneCards | GC13M020761. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:4284. GJB2. | ||||||||||||||||||||||||||||||
| HPA | CAB013093. | ||||||||||||||||||||||||||||||
| MIM | 121011. gene. 124500. phenotype. 148210. phenotype. 148350. phenotype. 149200. phenotype. 220290. phenotype. 601544. phenotype. 602540. phenotype. | ||||||||||||||||||||||||||||||
| neXtProt | NX_P29033. | ||||||||||||||||||||||||||||||
| Orphanet | 90635. Autosomal dominant nonsyndromic sensorineural deafness type DFNA. 90636. Autosomal recessive nonsyndromic sensorineural deafness type DFNB. 494. Keratoderma hereditarium mutilans. 477. KID syndrome. 2698. Knuckle pads - leuconychia - sensorineural deafness. 2202. Palmoplantar keratoderma - deafness. | ||||||||||||||||||||||||||||||
| PharmGKB | PA28695. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | NOG39645. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG009576. | ||||||||||||||||||||||||||||||
| InParanoid | P29033. | ||||||||||||||||||||||||||||||
| KO | K07621. | ||||||||||||||||||||||||||||||
| OMA | MDWSTLQ. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG4PK28F. | ||||||||||||||||||||||||||||||
| PhylomeDB | P29033. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| Reactome | REACT_11123. Membrane Trafficking. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| ArrayExpress | P29033. | ||||||||||||||||||||||||||||||
| Bgee | P29033. | ||||||||||||||||||||||||||||||
| Genevestigator | P29033. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000165474. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| InterPro | IPR000500. Connexin. IPR002268. Connexin26. IPR019570. Connexin_CCC. IPR017990. Connexin_CS. IPR013092. Connexin_N. [Graphical view] | ||||||||||||||||||||||||||||||
| PANTHER | PTHR11984. PTHR11984. 1 hit. PTHR11984:SF24. PTHR11984:SF24. 1 hit. | ||||||||||||||||||||||||||||||
| Pfam | PF00029. Connexin. 1 hit. PF10582. Connexin_CCC. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PRINTS | PR00206. CONNEXIN. PR01139. CONNEXINB2. | ||||||||||||||||||||||||||||||
| SMART | SM00037. CNX. 1 hit. SM01089. Connexin_CCC. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PROSITE | PS00407. CONNEXINS_1. 1 hit. PS00408. CONNEXINS_2. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||
| EvolutionaryTrace | P29033. | ||||||||||||||||||||||||||||||
| GenomeRNAi | 2706. | ||||||||||||||||||||||||||||||
| NextBio | 10698. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | CXB2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P29033 Secondary accession number(s): Q508A5 Q9NNY4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 13 Human chromosome 13: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
